Sign in

CIK 0001434647

  • Non-accelerated filer
  • Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205894398
Phone
+1 888-958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market buy Director bought 10,000 shares at $7.96 ($79,624)
  4. 4 Planned sale SVP, Finance & Corp Controller sold 3,000 shares at $7.86 ($23,588)
  5. 4 Planned sale CCO & EVP, Bus. Development sold 10,500 shares at $7.86 ($82,527)
  6. 4 Planned sale CFO & Treasurer sold 11,000 shares at $7.86 ($86,471)
  7. 4 Planned sale President and CEO sold 91,817 shares at an average $7.92 ($727,390)
  8. 4 Derivatives Options or other derivatives
  9. 4 Exercise or conversion SVP, Finance & Corp Controller acquired 11,666 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 4 Exercise or conversion CCO & EVP, Bus. Development acquired 35,333 shares (option exercise)
  12. 4 Exercise or conversion CFO & Treasurer acquired 43,333 shares (option exercise)
  13. 4 Exercise or conversion President and CEO acquired 233,333 shares (option exercise)
  14. 4 Open-market buy Director bought 500 shares at $7.92 ($3,958)
  15. 4 Open-market buy CFO & Treasurer bought 2,000 shares at $6.77 ($13,540)
  16. 4 Open-market buy Director bought 10,000 shares at $6.81 ($68,065)
  17. 4 Open-market buy Director bought 10,000 shares at $5.87 ($58,661)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 3 of 16 · 314 filings